PURPOSE OF REVIEW: This review is aimed at summarizing the recently published ISCHEMIA trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) and how its findings may impact cardiac imaging for stable ischemic heart disease (SIHD) moving forward. RECENT FINDINGS: The ISCHEMIA trial compared an initial invasive management strategy with goal of complete coronary revascularization versus an initial medical therapy strategy among stable patients with newly diagnosed moderate to severe myocardial ischemia on non-invasive testing. The trial results showed that an early invasive strategy did not reduce the incidence of major cardiovascular events over 3.2 years of follow-up as compared to optimal medical therapy in patients with SIHD. SUMMARY: The results of the landmark ISCHEMIA trial solidified the importance of guideline-directed medical therapy and have provided more evidence against the prevailing dogma that moderate to severe ischemia on traditional stress testing mandates coronary revascularization. This trial was not designed to compare different cardiac imaging and stress testing modalities for the assessment of coronary artery disease in patients undergoing their index evaluation for SIHD; however, its design, which included coronary computed tomographic angiography (CCTA) in most patients, and results have generated robust discussion regarding ways to improve non-invasive testing strategies in similar patient populations. We believe that increased utilization of CCTA to identify patients with and without high-risk SIHD, and advanced tests for ischemia, such as positron emission tomography and stress cardiac magnetic resonance imaging, when selected based on individual patient characteristics, may allow for improved decision-making and outcomes.
PURPOSE OF REVIEW: This review is aimed at summarizing the recently published ISCHEMIA trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) and how its findings may impact cardiac imaging for stable ischemic heart disease (SIHD) moving forward. RECENT FINDINGS: The ISCHEMIA trial compared an initial invasive management strategy with goal of complete coronary revascularization versus an initial medical therapy strategy among stable patients with newly diagnosed moderate to severe myocardial ischemia on non-invasive testing. The trial results showed that an early invasive strategy did not reduce the incidence of major cardiovascular events over 3.2 years of follow-up as compared to optimal medical therapy in patients with SIHD. SUMMARY: The results of the landmark ISCHEMIA trial solidified the importance of guideline-directed medical therapy and have provided more evidence against the prevailing dogma that moderate to severe ischemia on traditional stress testing mandates coronary revascularization. This trial was not designed to compare different cardiac imaging and stress testing modalities for the assessment of coronary artery disease in patients undergoing their index evaluation for SIHD; however, its design, which included coronary computed tomographic angiography (CCTA) in most patients, and results have generated robust discussion regarding ways to improve non-invasive testing strategies in similar patient populations. We believe that increased utilization of CCTA to identify patients with and without high-risk SIHD, and advanced tests for ischemia, such as positron emission tomography and stress cardiac magnetic resonance imaging, when selected based on individual patient characteristics, may allow for improved decision-making and outcomes.
Authors: Leslee Shaw; Raymond Y Kwong; Eike Nagel; Michael Salerno; Farouc Jaffer; Ron Blankstein; Vasken Dilsizian; Frank Flachskampf; Paul Grayburn; Jonathan Leipsic; Tom Marwick; Koen Nieman; Subha Raman; Partho Sengupta; William Zoghbi; Patricia A Pellikka; Madhav Swaminathan; Sharmila Dorbala; Randall Thompson; Mouaz Al-Mallah; Dennis Calnon; Donna Polk; Prem Soman; Rob Beanlands; Kirk N Garrett; Timothy D Henry; Sunil V Rao; Peter L Duffy; David Cox; Cindy Grines; Ehtisham Mahmud; Chiara Bucciarelli-Ducci; Sven Plein; John P Greenwood; Colin Berry; James Carr; Andrew E Arai; Venkatesh L Murthy; Terrence D Ruddy; Y Chandrashekhar Journal: JACC Cardiovasc Imaging Date: 2020-08
Authors: Judith S Hochman; Harmony R Reynolds; Sripal Bangalore; Sean M O'Brien; Karen P Alexander; Roxy Senior; William E Boden; Gregg W Stone; Shaun G Goodman; Renato D Lopes; Jose Lopez-Sendon; Harvey D White; Aldo P Maggioni; Leslee J Shaw; James K Min; Michael H Picard; Daniel S Berman; Bernard R Chaitman; Daniel B Mark; John A Spertus; Derek D Cyr; Balram Bhargava; Witold Ruzyllo; Gurpreet S Wander; Alexander M Chernyavskiy; Yves D Rosenberg; David J Maron Journal: JAMA Cardiol Date: 2019-03-01 Impact factor: 14.676
Authors: Kristopher D Knott; Andreas Seraphim; Joao B Augusto; Hui Xue; Liza Chacko; Nay Aung; Steffen E Petersen; Jackie A Cooper; Charlotte Manisty; Anish N Bhuva; Tushar Kotecha; Christos V Bourantas; Rhodri H Davies; Louise A E Brown; Sven Plein; Marianna Fontana; Peter Kellman; James C Moon Journal: Circulation Date: 2020-02-14 Impact factor: 29.690
Authors: David E Newby; Philip D Adamson; Colin Berry; Nicholas A Boon; Marc R Dweck; Marcus Flather; John Forbes; Amanda Hunter; Stephanie Lewis; Scott MacLean; Nicholas L Mills; John Norrie; Giles Roditi; Anoop S V Shah; Adam D Timmis; Edwin J R van Beek; Michelle C Williams Journal: N Engl J Med Date: 2018-08-25 Impact factor: 91.245
Authors: Sujith Kuruvilla; Nebiyu Adenaw; Arabindra B Katwal; Michael J Lipinski; Christopher M Kramer; Michael Salerno Journal: Circ Cardiovasc Imaging Date: 2013-12-20 Impact factor: 7.792
Authors: Rasha Al-Lamee; David Thompson; Hakim-Moulay Dehbi; Sayan Sen; Kare Tang; John Davies; Thomas Keeble; Michael Mielewczik; Raffi Kaprielian; Iqbal S Malik; Sukhjinder S Nijjer; Ricardo Petraco; Christopher Cook; Yousif Ahmad; James Howard; Christopher Baker; Andrew Sharp; Robert Gerber; Suneel Talwar; Ravi Assomull; Jamil Mayet; Roland Wensel; David Collier; Matthew Shun-Shin; Simon A Thom; Justin E Davies; Darrel P Francis Journal: Lancet Date: 2017-11-02 Impact factor: 79.321